Obesity

SAN ANTONIO — Patients with asthma and obesity had an increased risk for near-fatal asthma events and extended hospitalization compared with those who were not obese, a recent study showed.

SAN ANTONIO — Patients with asthma and obesity faced elevated risks for poor outcomes related to health, money and hospitalization, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Once-daily liraglutide 3 mg as an adjunctive to lifestyle intervention is associated with a reduction in body weight and HbA1c for adolescents with type 1 diabetes and obesity, according to a speaker.

Adding more physical education classes in grades one to nine could help lower the prevalence of obesity among school-aged children, according to a study published in Obesity.

In the United States, just half of patients with type 1 diabetes who had overweight or obesity received weight management lifestyle recommendations from providers or engaged in lifestyle modification, data show.

Once-weekly semaglutide 2.4 mg is associated with reductions in hunger and improved fullness at 20 weeks as well as improved craving control at 2 years, according to findings from the STEP 5 randomized controlled trial.

From bariatric surgery to lifestyle interventions to medications, there are several options available for treating obesity. However, determining the treatment plan that works best for each person remains a challenge.

There are many benefits of time-restricted eating and many mechanisms that may play a role. It has been shown that time-restricted eating affects the gut microbiome. When we restrict our eating window to only a certain period during the day, it increases the diversity of the gut microbiome and also affects the composition. We know that our gut microbiome may affect our insulin sensitivity and our immune function, and it may have beneficial effects on our cardiovascular system.

Despite more adults achieving lipid and BP control between 1999 and 2020, the prevalence of obesity has increased among adults with diabetes in the United States during this period, data show.

Bias based on size during pregnancy is a common experience particularly for women with overweight or obesity and can delay prenatal and postnatal care for women who fear weight stigma in the health care setting, according to experts.